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ABSTRACT: Hydroxyapatite (Ca5(PO4)3OH) is a well-known bioceramics material used in 
medical applications because of its ability to form direct chemical bonds with living tissues. 
In this context, we investigate the biocompatibility and dielectric properties of Sr2+-
substituted hydroxyapatite nanoparticles were synthesized by sol-gel method. The influence 
of strontium on the crystal structure, functional group, morphological, electrical properties, 
and biocompatibility of as-synthesized nano-hydroxyapatite samples was analyzed using X-
ray diffraction (XRD), Fourier transform infrared (FTIR) spectroscopy and field emission 
scanning electron microscopy (FE-SEM). Dielectrical properties of the bioactive Sr-HA 
sample were investigated by a dielectric impedance spectroscopy method. The observed 
results illustrate the incorporation of Sr2+ ions in the apatite lattice could influence the pure 
HA properties, by reducing the crystallite size and crystallinity quite consistent with the 
morphology variation. The ac conductivity (σac) increased with an increasing applied 
frequency confirmed that prepared HA sample exhibited the universal power law nature. 
Further, the in vitro drug loading and release studies using doxycycline as a model drug 
demonstrate that the Sr2+ -HA nanoparticles show high drug adsorption capacity and 
sustained drug release. Thus, the improved bioceramics system could be a promising 
candidate for future biomedical applications. 
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1. Introduction 
Bioactive nanomaterials have more attention for their 
use in specific clinical applications. In particularly, the 
synthetic bioactive nanomaterials to repair and reconstruction 
of hard tissues has appreciably employed in the past years [1, 
2]. Hydroxyapatite (Ca10(PO4)6 (OH)2, HA) is most eminent 
bioceramic material since it is chemical and structural 
similarity to the mineralized constituent of hard tissues. This 
biomaterial attributes infer good biocompatibility and 
osteoconductivity [3]. However, synthetic HA varies 
significantly from other bioactive material due to its 
crystallinity, composition, less reactivity with bone, inferior 
osteogenic capacity and poor mechanical strength [4].  In 
order to ionic substitution convenience way to tailoring their 
characteristic properties of synthetic HA and overcomes the 
relative drawbacks [5]. The inclusion of well biological 
desirable ions with HA could be an increase in bone mineral 
density and it is direct to use in bone implant. Natural human 
bone contains several trace elements such as Mg2+, Sr2+, Zn2+ 
and F- which play an important role in enhance 
osteoconductivity and mechanical strength of bone [6]. 
Among the divalent cations, Sr2+ is particularly attractive due 
to beneficial effects in the treatment of osteoporosis. 
Incorporation of strontium into HA lattice can leads to 
favorable effects on biomaterial properties, such as change in 
crystallinity, solubility in chemical solvents, and dissolution 
which may in turn influence on bioactive property [3]. In 
addition, in vitro and in vivo study has been deals with the 
Sr2+ enhances bone formation and reduces bone loss which 
expecting leads to a increase in bone mineral density  and 
improved bone strength [7].  
Taken together, strontium containing tooth paste was 
developed to increase the remineralization of dental enamel. 
Thus many efforts have been made to improve the bioactivity 
and biocompatibility of Sr-substituted HA [8]. Frasnelli et al. 
[9] strontium-substituted hydroxyapatite nanoparticles could 
be potentially used to bone tissue and tissue regeneration. 
Suganthi et al. [10] highlighted the fibrous growth of Sr 
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substituted HA increased the surface area leading to the 
prolonged release of drug compared to pure HA. In vitro and 
in vivo studies revealed the inclusion of Sr into HA structure 
increases bone forming ability and improved bone strength 
for human hard tissues [4]. Hence, Sr2+ is an appreciably and 
topical ion for substitution into HA due to its important role in 
the biomineralization of hard tissues. Several synthetic 
methods employed to generate hydroxyapatite nanoparticles 
such as microwave assisted, hydrothermal, sol-gel, 
solvothermal, and high-gravity precipitation methods. Among 
theses, the Sol-gel method extends eminent advantages 
including high phase purity, homogenous mixture, and low 
synthesis temperature [11-14]. The major aim of this work to 
synthesize lower amount of Sr2+-substituted HA nanoparticles 
using sol-gel method. The influence of Sr2+ ions incorporation 
on crystal structure, morphology, dielectric properties and 
drug release of HA nanoparticles were investigated. 
Biocompatibility was carried out using human lung 
adenocarcinoma epithelial cells (A549) to estimate the 
cytotoxicity of the Sr2+-substituted HA nanoparticles.    
2. Materials and Method 
2.1. Source Materials 
The starting chemicals used in this experiment were 
of analytical grade without further any purification. Calcium 
nitrate tetrahydrate (Ca(NO3)2.4H2O, 98.0 % purity, Merck), 
diammonium hydrogen phosphate (NH4)2HPO4, 99% purity, 
Merck), strontium  nitrate hexahydrate (Sr(NO3)2.6H2O, 98% 
purity, Sigma-Aldrich), sodium hydroxide (NaOH, 98% 
purity, Sigma-Aldrich) pellets, (C10H16N2O8, 98% purity, 
LobaChemie) were obtained commercially. Millipore water 
was used as the solvent throughout the experiments. 
2.2. Sample Preparation 
In briefly, specific quantities of source materials Ca2+ 
and Sr2+ mixed in millipore water to form solution A and the 
total amount of Ca2+ and Sr2+in 0.5 M. 0.3 M of diammonium 
hydrogen phosphate were dissolved in millipore water to form 
solution B. The Ca+ dopant: P molar ratio was adjusted at 1.67. 
Then, solution B was added dropwise into solution A with 
vigorous stirring for 1 h at room temperature. The ammonia 
solution was used to maintain the pH value at 10. After the 
addition, the milky solution was observed and kept at 90 °C 
for overnight. Subsequently, the attained precipitate was 
filtered off and washed several times with millipore water and 
ethanol. The resulting white gel was dried at 120 °C for about 
14 h in hot air oven. Finally, the derived white powders were 
calcined at 700 °C for 2 h heating rate at 20 °C min-1.The 
reaction for the formation of Sr-substituted HA is expressed as 
follows: 
(𝟏𝟎 − 𝒙)𝑪𝒂𝟐+ + 𝒙 𝑺𝒓𝟐+ + 𝟔𝑷𝑶𝟑−𝟒 + 𝟐𝑶𝑯
−
→ 𝑪𝒂𝟏𝟎−𝒙𝑺𝒓𝒙(𝑷𝑶𝟒)𝟔 (𝑶𝑯)𝟐  
2.3. Characterization techniques   
Crystal structure of the as-synthesized HA 
nanoparticles were of characterized by Bruker D8 Advance X-
ray diffractometer (XRD) equipped with Cu Kα radiation 
(λ=1.542 Å). Fourier transform Infrared (FT-IR) spectra are 
recorded in the wave number range of 4000–400 cm-1 using 
a Nicolet 380 spectrometer. The surface morphology was 
analyzed using field emission scanning electron microscope 
(FESEM, Zeiss, 6027 Merlin compact).  The dielectric and 
alternating current conductivity properties were examined by 
using a Hioki 3532-50 LCR Hi Tester at room temperature. 
2.3.1. In vitro drug release 
To examine the in vitro drug release, Amoxicillin was 
used to selected model drug in this study [15]. 10 mg of as-
synthesized HA nanoparticles were mixed with 5 mg of 
amoxicillin and made it into a pellet. The pellet immersed in 
PBS solution was kept maintained at room temperature. The 
release medium was drawn at appropriate time intervals and 
the amount of drug released was calculated by UV- Vis 
spectrophotometer (Shimadzu, UV 3600) at 230 nm. 
2.3.2. In vitro Cytotoxicity 
The human lung carcinoma epithelial- A549 cell line 
were grown in eagles minimum essential medium containing 
10% fetal bovine serum (FBS). The cell culture was maintained 
in a humidity atmosphere at 37 ºC, with 5% CO2 and 95% air 
and the culture medium was changed twice a week. To 
evaluate the cytotoxicity of the prepared sample at different 
concentrations, Viable cells were counted by using a 
hemocytometer and diluted with medium containing 5% FBS 
to give a final density of 1x105 cells/mL in a humidified 
atmosphere. The medium with MTT solution was discarded, 
the addition of DMSO (100 µL) and the plate was shaken for 
10 min before measuring absorbance at 570 nm using 
photometer. The cell viability in % was determined using the 
following formula [6],  
𝐶𝑒𝑙𝑙 𝑉𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 % =
𝑇𝑒𝑠𝑡
𝐶𝑜𝑛𝑡𝑟𝑜𝑙
𝑋100                             [1] 
3. Results and discussion 
3.1. XRD Analysis   
 The X-ray powder diffraction patterns of the pure HA 
and Sr-substituted HA nanoparticles are shown in Fig.1. The 
major diffraction peaks correspond to the (002), (102), (211), 
(112), (300), (202), (301), (113), (203), (222) (213) and 
(004) crystal planes are obviously in good agreement with the 
standard JCPDS reference (01–084) and the secondary phase 
of      β-tricalciumphosphate (β-TCP) (09–0169) appears in 
both samples. All the diffraction peaks are well indexed as 
pure hexagonal phase structure, and no discernable peaks of 
third phase are found. The sharp diffraction peaks manifests 
that the pure and Sr-HA samples have good crystalline nature. 
However, for the Sr substituted HA sample, the diffraction 
peaks exhibited a slight increase  
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Fig. 1. XRD patterns of Pure and Sr-substituted HA 
nanoparticles by Sol-gel method. 
In peak width, which indicating the decreased crystallinity 
and crystallite size.  
The peak broadening relates to crystallite size (D) 
according to the following Scherrer’s Equation [2], 
𝐷 =
0.9𝜆
𝛽𝑐𝑜𝑠Ѳ
                                              [2] 
Where λ is the wavelength of the X-ray (λ=0.154 nm), Ѳ is 
the diffraction angle in degree and β is the full-width at half 
maximum (FWHM) in radian. By pure HA and Sr-substituted 
HA, the average crystallite size was found to be in the range 
of 34-39 nm (Table 1). The estimated value of crystallite size 
was decreased by the effect of Sr2+. Considering the ionic 
radius, for Sr2+ (0.113 Å) it is greater than that of the Ca2+ 
(0.99 Å). It is expected that the incorporation of Sr might 
cause the shrinkage (size reduction) of the apatitic structure 
[16].  
While the crystallinity (Xc) of the as-synthesized 
nanoparticles [17] was calculated from the following 
Equation [3],   
𝑋𝑐 = (
 0.24
𝛽
)
3
 [3] 
The average crystallinity on Sr substituted HA sample 
was similar to that of crystallite size calculated. The decreased 
crystallinity and crystallite size of Sr incorporated HA samples 
were further confirmed by FESEM results. In order to keep 
charge compensation mechanism, the vacancies and defects 
are generated and this would affect the crystallinity [8]. 
The lattice parameters a and c for the obtained 
hexagonal structure were calculated from (211) and (002) 
planes respectively using the following relation  
1
𝑑(ℎ𝑘𝑙)
2 =
4
3
(
ℎ2 + ℎ𝑘 + 𝑘2
𝑎2
) +
𝑙2
𝑐2          
       [4]               
 
Fig. 2. FTIR spectra of pure and Sr2+substituted HA 
nanoparticles. 
The lattice parameters of pure HA varied with small 
amount of strontium. In the case, both ions Sr2+ and Ca2+ have 
similar charges but the size difference may linked with an 
expansion of apatite lattice parameters. The slight change of 
the lattice parameters of Sr-HA clearly revealed the Sr ions 
were structurally incorporated into HA lattice. Moreover, 
Stokes-Wilson equation was used to determine the lattice 
strain (Ɛ) 
Ɛ =
β
4tanθ
                                                         [5] 
There is a broadening observed at FWHM of the XRD 
pattern with inclusion of Sr2+. This broadening is caused by 
not only the crystalline size-induced but also to the strain-
induced broadening. The influence of lattice strain values on 
the XRD peak reflection is clear from the Table 1.  
3.2. FTIR analysis 
The functional group analysis of pure and Sr-
substituted HA nanoparticles confirmed the fundamental 
vibration bands corresponding to hydroxyapatite as shown in 
Fig. 2. The bands associated with different characteristic 
vibration modes around 466, 568, 606, 976 and 1030-1100 
cm-1 demonstrates the PO4 groups of the apatite structure 
[18]. The absorption band at 3442 cm-1 and 1695 cm-1 
correspond to absorbed water. The strongest band at 1037-
1100 cm-1, which appears as a doublet in Sr substituted HA 
sample was assigned to the phosphate stretching vibration. 
The weak band at about 453 cm-1 associated to the phosphate 
banding mode. The band at 568-606 cm-1 appears as a 
doublet was assigned to the PO43- bending modes [19]. The 
weak vibrational peak at 1448 cm-1 is attributed to the 
presence of carbon moieties on pure HA sample formed 
during the stage of sample preparation.  
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Table 1 The average crystallite size and crystallinity values for synthesized HA samples 
 
3.3. Morphological analysis 
FESEM micrographs of the synthesized pure HA and 
Sr-substituted HA nanoparticles are exhibited in Fig.3. The 
surface morphology of pure HA nanoparticles show spherical 
shaped morphology (Fig.3 (a)) with average diameter ranging 
from 70 to 86 nm. Micrographs revealed that Sr ions doping 
influenced the particle size of the HA nanoparticles (Fig.3 (b)). 
In Sr- HA sample, formation of spherical shaped with loosely 
agglomeration of primary particles with averages diameter 
ranging below 70 nm. The agglomeration of both samples 
consisting of interconnected elongated spherical-like 
particles. The decrease in the size of HA nanoparticles was also 
confirmed by XRD analysis as shown in Table 1.  
3.4. Dielectric and AC conductivity   
The dielectric possession of the material plays a vital 
role in various areas of science and engineering. The real part 
of dielectric permittivity, Ɛʹ attributed to the dielectric 
constant and the imaginary part Ɛʹʹ, the dielectric loss, and the 
AC conductivity (σac) are calculated by the following relations 
[14] 
Ɛ∗ = Ɛ′ − 𝑖Ɛ′′     (6) 
Ɛ′ =  
Cp t
Ɛ0A
     (7) 
Ɛ′′ =
Gc t
Ɛ0Aω
     (8) 
Fig .3. FESEM micrograph of (a) pure and (b) Sr2+-substituted 
HA nanoparticles. 
σac = 2πfƐ0Ɛ′tan δ    (9) 
Where Ɛ0 is the permittivity of free space charge (Ɛ0=8.854 
x10-14 F/cm), A is the area of the electrode, t is thickness of 
the sample, tanδ is the tangent loss factor (tanδ=Ɛ''/ Ɛ'), Cp and 
Gc are the capacitance and conductance, and f is frequency of 
applied ac field and 𝜔 = 2𝜋𝑓 is the angular Fig. frequency 
respectively. 
 
Fig 4. The frequency variation of (a) dielectric constant (𝜺′), 
(b) dielectric loss (𝜺"), (c) Ac conductivity (𝜎𝑎𝑐), (d) 
capacitance (𝐶𝑝) and (e) Impedance. 
 
Sample Chemical formula Crystallite size  (D) 
(nm) 
Crystallinity 
(XC ) 
Lattice Parameter 
(Å) 
Strain 
(ԑ) 
x 10-3 a            b 
Pure HA Ca10(PO4)6(OH)2 38.82 1.7401 9.4261 6.7762 0.2232 
Sr-HA Ca0.95Sr0.05(PO4)6(OH)2 33.42 1.3040 9.4422 6.8102 0.2725 
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Fig. 5.In vitro amoxicillin drug loading and release of pure 
and Sr-HA as a function of time. 
The dielectric permittivity (Ɛʹ) dependence on 
applied frequency of the as-synthesized HA nanoparticles are 
shown in Fig. 4 (a). The change in the dielectric constant of 
both pure and Sr-HA sample is due to the electrical 
polarization. The incorporation of Sr into Ca ion in HA 
changes the dielectric dipole moments of the hydroxyl ions 
having an ionic structure are oscillated with the frequency of 
applied electric field [20]. The change in oscillations of dipoles 
causes a change in the dielectric constant. The dielectric loss 
(Ɛʹʹ) established using Eq. 8, also gradually decreases with 
increasing the frequency and inclusion of strontium ions as 
shown in Fig. 4 (b). The reduction of dielectric loss (Ɛʹʹ) at low 
frequencies is attributed to the migration of ions in the HA 
samples.  
Fig 4(c) shows that the ac conductivity (σac) 
gradually increases with frequency from 50 Hz to 5MHz at 
room temperature for HA and Sr-HA samples and obeys the 
universal power law. However the conductivity mechanism of 
the samples is confirmed by using the well-known Jonscher 
relation [21]: 
  𝜎𝑎𝑐 =  𝜎𝑑𝑐 + Bω
s                      (10) 
Where σdc is the direct current conductivity, B is a constant, ω 
is the angular frequency, and s is an  exponent. In this regard, 
pure HA and Sr substituted HA samples exhibit the 
conductivity mechanism, which was in good agreement with 
the previous results [22, 23]. The capacitance and impedance 
values decrease with frequency (Fig. 4 d &e), but the values of 
the ac conductivity increase. The capacitance decays for all 
the samples in the high-frequency region that follow the 
conductivity [14]. The measured resistance values range from 
105-106Ω, and this value corresponds to insulator behavior of 
pure and Sr substituted HA the samples. 
3.5. In Vitro drug loading and release   
 The UV-vis demonstrates that amount of 
doxycycline drug loading efficiency of pure and Sr-
substituted HA nanoparticles corresponding with time are 
shown in Fig.5 (a). This result interesting to note that loading 
and prolonged realise of drug has been observed for both 
samples.  Nevertheless, the percentage of drug loading was  
 
 
 
 
 
 
 
 
Fig.6. The Cell viability of A549 cells against Sr-HA 
Nanoceramics at different concentrations. 
Found to be 43.1% for pure HA and 46.1% for Sr0.1HA 
samples. Doxycycline have easily water soluble drug and 
contains electron-donor groups likely to generate stable 
complexes with Ca2+ and Sr2+ thus presenting a strong affinity 
for the adsorption on HA surface [24]. 
The amounts of drug release from pure HA, and Sr-
HA was shown in Fig. 5 (b). It revealed that the release of 
amoxicillin drug from the Sr substituted HA was relatively 
faster than pure HA samples. An initial burst release of about 
40 % within 7- 8 h for both samples, after the rapid release 
stage followed by the prolonged release. While the rate of drug 
release attained at maximum for both samples time takes over 
48 h. The initial stage of rapid drug release may be attributed 
to the adsorption of drugs on the outer surface of samples [15, 
25]. The slow release may response to the high affinity 
between drug molecules and the inner apatite surface. It is 
interesting to note that the as-synthesized HA nanoparticles 
can exhibit sustained and prolonged release for the promising 
application of drug vehicle in targeted sites.    
3.6. Cell viability in vitro  
The MTT assay is a convenient approach to find the 
cell viability of bioceramic materials. The in vitro cytotoxicity 
of Sr substituted HA was evaluated by MTT assay against 
human lung carcinoma epithelial-A549 cell line, and pure HA 
was used as a control as shown in Fig. 6. The cells exposed to 
the samples different concentration (10, 25 and 50 μg mL-1) 
shows no remarkable changes in the MTT signal as compared 
to control. The cell viabilities are all over 90 %, and the sample 
Sr substituted HA is exhibited better biocompatibility. 
Therefore, free toxicity of Sr-HA biomaterials can be potential 
candidate for various biomedical applications.    
4. Conclusions  
In summary, pure and Sr substituted HA 
nanoparticles were successfully synthesized by sol-gel method 
and their structural and electrical properties were also 
investigated. The inclusion of Sr ions in the apatite structure 
could influence on pure HA properties, by reducing their 
crystallite size, crystallinity good harmony with the 
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morphology analysis. Functional group analysis from the FT-
IR spectra confirmed the formation of HA due to the presence 
of hydroxyl and phosphate groups in both samples. The 
relative permittivity, dielectric loss and alternating current 
conductivity changes with increasing frequency and the ac 
conductivity (σac) increased with an increasing applied 
frequency confirmed that HA sample exhibited the universal 
power law nature. The Sr2+ substituted HA sample showed 
extended drug release and exhibited better biocompatibility. 
Hence, thus bioceramics can be potential candidate for 
various biomedical and optoelectronic applications. 
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